Enhanced glutathione production by CLL cells has been implicated in ROS generating drug resistance and increased expression of anti-apoptotic proteins, such as MCL1 [55] Previously, it has been shown that BTK directly modulates TP53. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.